Diagnos Laboratorium Utama PT Tbk (DGNS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.008x

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has a cash flow conversion efficiency ratio of 0.008x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.52 Billion ≈ $88.96K USD) by net assets (Rp194.00 Billion ≈ $11.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Diagnos Laboratorium Utama PT Tbk - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DGNS total debt and obligations for a breakdown of total debt and financial obligations.

Diagnos Laboratorium Utama PT Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GreenPro Capital Corp NASDAQ:GRNQ	-0.094x
Intikeramik Alamasri Industri JK:IKAI	0.041x
RENN Fund Inc NYSE MKT:RCG	-0.001x
Cordoba Minerals Corp V:CDB	14.511x
Premium Catering (Holdings) Limited NASDAQ:PC	N/A
Lighting and Equipment Public Company Limited BK:L&E	0.128x
Bankers Investment Trust LSE:BNKR	0.029x
Israel China Biotechnology (ICB) Ltd TA:ICB	-0.415x

Annual Cash Flow Conversion Efficiency for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual cash flow conversion efficiency of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see DGNS stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp196.13 Billion ≈ $11.49 Million	Rp27.30 Billion ≈ $1.60 Million	0.139x	+106.49%
2023-12-31	Rp195.59 Billion ≈ $11.46 Million	Rp13.18 Billion ≈ $772.50K	0.067x	+335.77%
2022-12-31	Rp210.43 Billion ≈ $12.33 Million	Rp-6.02 Billion ≈ $-352.51K	-0.029x	-109.80%
2021-12-31	Rp201.80 Billion ≈ $11.82 Million	Rp58.87 Billion ≈ $3.45 Million	0.292x	+10.19%
2020-12-31	Rp99.07 Billion ≈ $5.80 Million	Rp26.23 Billion ≈ $1.54 Million	0.265x	+9.86%
2019-12-31	Rp46.46 Billion ≈ $2.72 Million	Rp11.20 Billion ≈ $656.06K	0.241x	-62.25%
2018-12-31	Rp13.27 Billion ≈ $777.31K	Rp8.47 Billion ≈ $496.20K	0.638x	+388.54%
2017-12-31	Rp3.22 Billion ≈ $188.58K	Rp-712.00 Million ≈ $-41.72K	-0.221x	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$19.48 Million

Rp332.50 Billion IDR

Market Cap Rank

#25106 Global

#548 in Indonesia

Share Price

Rp266.00

Change (1 day)

-4.32%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74